| Literature DB >> 29155832 |
Melanie Plazy1,2, Delphine Perriat1,2, Dumile Gumede3, Sylvie Boyer4, Deenan Pillay3,5, François Dabis1,2, Janet Seeley3,6, Joanna Orne-Gliemann1,2.
Abstract
BACKGROUND: We aimed to describe the field experiences and recommendations of clinic-based health care providers (HCP) regarding the implementation of universal antiretroviral therapy (ART) in rural KwaZulu-Natal, South Africa.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29155832 PMCID: PMC5695789 DOI: 10.1371/journal.pone.0186883
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Study population and sample–Hlabisa sub-district, South Africa, 2016.
| Total population (enrolled in the quantitative component) | Qualitative study sample | Sample characteristics | |||||
|---|---|---|---|---|---|---|---|
| Interviewee | Gender | Age | Years of experience in HIV care | ||||
| Clinic-based managers | 3 (all enrolled) | 2 IDIs | IDI TasP Nurse Manager 01 | F | 44 | 11 | |
| IDI TasP Nurse Manager 02 | F | 39 | 8 | ||||
| Nurses | 19 (15 enrolled) | 4 IDIs | IDI TasP Nurse 01 | F | 35 | 8 | |
| IDI TasP Nurse 02 | F | 53 | 8 | ||||
| IDI TasP Nurse 03 | F | 34 | 6 | ||||
| IDI TasP Nurse 04 | F | 71 | 10 | ||||
| 1 FGD with seven participants | FGD TasP Nurse, P1 | M | 28 | 6 | |||
| FGD TasP Nurse, P2 | F | 72 | 9 | ||||
| FGD TasP Nurse, P3 | F | 71 | 8 | ||||
| FGD TasP Nurse, P4 | F | 34 | 8 | ||||
| FGD TasP Nurse, P5 | F | 53 | 9 | ||||
| FGD TasP Nurse, P6 | F | 35 | 5 | ||||
| FGD TasP Nurse, P7 | F | 28 | 5 | ||||
| ART counsellors | 15 (all enrolled) | 2 IDIs | IDI TasP Counsellor 01 | F | 46 | 16 | |
| IDI TasP Counsellor 02 | F | 31 | 9 | ||||
| 1 FGD with six participants | FGD TasP Counsellor, P1 | F | 58 | 13 | |||
| FGD TasP Counsellor, P2 | F | 32 | 6 | ||||
| FGD TasP Counsellor, P3 | F | 58 | 14 | ||||
| FGD TasP Counsellor, P4 | M | 29 | 6 | ||||
| FGD TasP Counsellor, P5 | F | 54 | 14 | ||||
| FGD TasP Counsellor, P6 | F | 37 | 13 | ||||
| ART nurses | 51 (40 enrolled) | 3 IDIs | IDI DoH Nurse 01 | F | 47 | 17 | |
| IDI DoH Nurse 02 | F | 63 | 7 | ||||
| IDI DoH Nurse 03 | F | 50 | 6 | ||||
| Government clinic managers | 18 | 2 IDIs | IDI DoH Gov. Clinic Manager 01 | F | 31 | 3 | |
| IDI DoH Gov. Clinic Manager 02 | F | 56 | 17 | ||||
HCP: health care providers; IDI: individual interview; FGD: focus-group discussion;
TasP: Treatment as Prevention trial; DoH: Department of Health; ART: antiretroviral therapy
F: Female; M: Male; P: Participant
* Total number of HCPs per category at the time of beginning the study in April 2016 (in brackets, number of HCPs enrolled in the quantitative component)
** DoH government clinic managers were not targeted by the quantitative component of the survey